HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibiotic tackles tough infections in vulnerable patients
Disease control TerminatedThis study looked at whether the antibiotic ceftolozane-tazobactam can treat serious Pseudomonas infections in people with blood cancers or who had a stem cell transplant. Participants received the drug through a vein for 10 to 14 days. Researchers tracked survival and infection …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Radiation after failed CAR t: small study halted early
Disease control TerminatedThis pilot study tested whether adding radiation therapy could help people with lymphoma that did not respond to CAR T cell therapy. Only 3 participants were enrolled before the study was stopped early. The main goal was to check safety and side effects of the radiation.
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC